Tracer library / [188Re]Re-Liposome

[188Re]Re-Liposome

Also written as [188Re]Re-Liposome
Radionuclide
Modality
—
Production route
—
Stage
Preclinical
Syntheses indexed
0
Gastrointestinal and colorectal cancerDosimetry and biodistribution studiesPreclinical only, no clinical indication yet

What it is

Compound class
Radiolabeled PEGylated nanoliposome
Target / mechanism
—
Clinical application
Colon cancer / colonic peritoneal carcinomatosis PMID 22114492
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [188Re]Re-Liposome, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 3 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 22114492, 23067100, 25027866. Stage set/updated at stage 39 from PMID 22114492: 'Colon carcinoma peritoneal metastatic BALB/c mice were intravenously administered (188)Re-liposomes.'.